Biogen | BIIB - EPS Earnings Per Share


Biogen reported $3.57 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Jun/2026 3.21 5.47 Jul/16
FY2026Q1 Mar/2026 3.57 3.06 3.02 Apr/29
FY2025Q4 Dec/2025 1.99 1.74 3.44 Feb/06
FY2025Q3 Sep/2025 4.81 3.84 4.08 Oct/30
FY2025Q2 Jun/2025 5.47 4.08 5.28 Jul/31




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
ALKERMES USD -0.4 0.69 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.88 0.35 Mar/2026
Sanofi EUR 2.17 2.84 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Teva Pharmaceutical Industries USD 1.57 1.41 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026